The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
If you’re starting a weight loss journey, you might have stumbled upon tirzepatide — the drug approved by the FDA (U.S. Food and Drug Administration) under the brand names Mounjaro and Zepbound.
"We're suckers for quick fixes," Emily Feivor, a registered dietician, tells PEOPLE about the claim that honey, lemon, water, ...
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
Tirzepatide is the active ingredient in Eli ... will be restricted from making what are essentially copies of the brand-name version. These copies use the same active ingredient — in this ...
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...
The Healthy on MSN13d
FDA Announcement: The First Generic GLP-1 Shot Has Just Been ApprovedThis may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
Similarly, tirzepatide has been approved for type 2 diabetes under the name Mounjaro and for obesity under the name Zepbound (or Mounjaro in some regions). On 20 December, tirzepatide also ...
Two medical spas have been sued by Eli Lilly for selling unapproved products that claim to contain tirzepatide. Tirzepatide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback